New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.
作者信息
van Krieken J Han
机构信息
Department of Pathology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
出版信息
J Hematop. 2010 Jun;3(1):47-58. doi: 10.1007/s12308-010-0060-x. Epub 2010 Jun 2.
Abstract
摘要
相似文献
1
New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.恶性淋巴瘤病理学的新进展：对2009年10月至2010年1月发表的文献综述
J Hematop. 2010 Jun;3(1):47-58. doi: 10.1007/s12308-010-0060-x. Epub 2010 Jun 2.
2
New developments in the pathology of malignant lymphoma: a review of the literature published from October 2014-December 2014.恶性淋巴瘤病理学的新进展：2014年10月至2014年12月发表文献综述
J Hematop. 2015 Mar 7;8(1):21-29. doi: 10.1007/s12308-015-0240-9. eCollection 2015 Mar.
3
New developments in the pathology of malignant lymphoma: a review of literature published from January 2015 to April 2015.恶性淋巴瘤病理学的新进展：2015年1月至2015年4月发表文献综述
J Hematop. 2015 Jun 17;8(2):71-79. doi: 10.1007/s12308-015-0249-0. eCollection 2015 Jun.
4
New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008.恶性淋巴瘤病理学的新进展：2008年1月至4月发表文献综述
J Hematop. 2008 Jul;1(1):37-45. doi: 10.1007/s12308-008-0010-z.
5
New developments in the pathology of malignant lymphoma. A review of the literature published from January-April 2016.恶性淋巴瘤病理学的新进展。对2016年1月至4月发表的文献综述。
J Hematop. 2016 Jun 13;9(2):73-83. doi: 10.1007/s12308-016-0277-4. eCollection 2016 Jun.
6
New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009.恶性淋巴瘤病理学的新进展：2009年1月至8月发表文献综述
J Hematop. 2009 Sep 26;2(3):171-83. doi: 10.1007/s12308-009-0046-8.
7
New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2017.恶性淋巴瘤病理学的新进展：2017年1月至4月发表文献综述
J Hematop. 2017 Jul 22;10(1):25-33. doi: 10.1007/s12308-017-0295-x. eCollection 2017 Mar.
8
New developments in the pathology of malignant lymphoma: a review of the literature published from May 2015-September 2015.恶性淋巴瘤病理学的新进展：2015年5月至2015年9月发表文献综述
J Hematop. 2015 Nov 19;8(4):225-234. doi: 10.1007/s12308-015-0262-3. eCollection 2015 Dec.
9
New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.恶性淋巴瘤病理学的新进展：2008年8月至12月发表文献综述
J Hematop. 2009 Mar;2(1):50-61. doi: 10.1007/s12308-009-0027-y.
10
New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008.恶性淋巴瘤病理学的新进展：2008年5月至7月发表文献综述
J Hematop. 2008 Sep;1(2):145-60. doi: 10.1007/s12308-008-0012-x.
本文引用的文献
1
Comparison of BIOMED-2 versus laboratory-developed polymerase chain reaction assays for detecting T-cell receptor-gamma gene rearrangements.BIOMED-2 与实验室研发的聚合酶链反应检测 T 细胞受体-γ基因重排的比较。
J Mol Diagn. 2010 Mar;12(2):226-37. doi: 10.2353/jmoldx.2010.090042.
2
EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.EBV 阳性黏膜溃疡——26 例与各种免疫抑制来源相关的研究。
Am J Surg Pathol. 2010 Mar;34(3):405-17. doi: 10.1097/PAS.0b013e3181cf8622.
3
C-C chemokine receptor 1 expression in human hematolymphoid neoplasia.C-C 趋化因子受体 1 在人类造血淋巴肿瘤中的表达。
Am J Clin Pathol. 2010 Mar;133(3):473-83. doi: 10.1309/AJCP1TA3FLOQTMHF.
4
Epstein-Barr virus-associated diffuse large B-cell lymphoma arising on cardiac prostheses.心脏假体上发生的与 Epstein-Barr 病毒相关的弥漫性大 B 细胞淋巴瘤。
Am J Surg Pathol. 2010 Mar;34(3):377-84. doi: 10.1097/PAS.0b013e3181ce9128.
5
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.抑制乳酸脱氢酶 A 会诱导氧化应激并抑制肿瘤进展。
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2037-42. doi: 10.1073/pnas.0914433107. Epub 2010 Jan 19.
6
Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas.癌睾丸抗原 CT45 在经典型霍奇金淋巴瘤和其他 B 细胞淋巴瘤中的表达。
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3093-8. doi: 10.1073/pnas.0915050107. Epub 2010 Jan 26.
7
Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma.p53 肿瘤抑制活性丧失与套细胞淋巴瘤的不良预后相关。
Int J Oncol. 2010 Mar;36(3):699-706. doi: 10.3892/ijo_00000545.
8
Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.基因组和基因表达谱分析定义了惰性形式的套细胞淋巴瘤。
Cancer Res. 2010 Feb 15;70(4):1408-18. doi: 10.1158/0008-5472.CAN-09-3419. Epub 2010 Feb 2.
9
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.IGH-BCL2 和 MYC 同时重排的 B 细胞淋巴瘤是具有侵袭性的肿瘤，其临床和病理特征与 Burkitt 淋巴瘤和弥漫性大 B 细胞淋巴瘤不同。
Am J Surg Pathol. 2010 Mar;34(3):327-40. doi: 10.1097/PAS.0b013e3181cd3aeb.
10
Polymorphous lymphoproliferative disorder: a clinicopathological analysis.多形性淋巴组织增生异常：临床病理分析。
Virchows Arch. 2010 Mar;456(3):269-76. doi: 10.1007/s00428-010-0880-1. Epub 2010 Jan 29.
Zotero 插件